These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18932460)

  • 21. Choline; the cause of lipocaic lipotropic action on fatty rat livers.
    WICK AN
    Arch Biochem; 1949 Jan; 20(1):113-7. PubMed ID: 18104401
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of parenterally administered protein hydrolysates on the external secretory activity of the human pancreas].
    Shlygin GK; Laktaeva TV; Berezov IuE; Ostrin PI; Krazas IS
    Biull Eksp Biol Med; 1972 Jan; 73(1):20-3. PubMed ID: 5011183
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of lipotropic substances on various types of experimental hepatic steatosis; changes in enzyme picture].
    BERGAMINI A; BENDANDI A; CHIEREGO G; MAGGI G
    Minerva Med; 1955 Dec; 46(101):1863-4. PubMed ID: 13288137
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatty liver in man and the role of lipotropic factors.
    GABUZDA GJ
    Am J Clin Nutr; 1958; 6(3):280-97. PubMed ID: 13533314
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phospholipase A2 activity of extracts of pancreatic juice and pancreas from humans, rats and dogs].
    Belleville J; Clément J
    J Physiol (Paris); 1969; 61 Suppl 1():87. PubMed ID: 5408420
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipotropic agents and sulfur-containing amino acids.
    WHITE BV
    Conn State Med J; 1949 Apr; 13(4):349-52. PubMed ID: 18116255
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of pancreatic lipotropic factors on disorders of fat metabolism in diabetes on high fat diet].
    GIORDANO A; PEGNI U
    Riv Crit Clin Med; 1950 Sep; 50(3-4):304-22. PubMed ID: 14808847
    [No Abstract]   [Full Text] [Related]  

  • 28. Sucrose fatty acid esters suppress pancreatic secretion accompanied by peptide YY release in pancreatico-biliary diverted rats.
    Hira T; Takahashi K; Hara H
    Exp Physiol; 2007 Jul; 92(4):687-94. PubMed ID: 17384118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of trypsinogen in the lipotropic fraction.
    PEANASKY RJ; LASKOWSKI M
    Proc Soc Exp Biol Med; 1953; 83(4):686-8. PubMed ID: 13120854
    [No Abstract]   [Full Text] [Related]  

  • 30. [Considerations on liver cirrhosis, fatty liver and lipotropic substances].
    VAN EECKHOUTTE P
    Belg Tijdschr Geneesk; 1953 Mar; 9(6):237-45. PubMed ID: 13051387
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoreactive secretin and exocrine pancreatic secretion.
    Chey WY
    Gastroenterology; 1978 Nov; 75(5):912-3. PubMed ID: 700332
    [No Abstract]   [Full Text] [Related]  

  • 32. Preparation of a pancreas derivative having lipotropic activity.
    BOSSHARDT DK; CIERESKO LS; BARNES RH
    Am J Physiol; 1951 Aug; 166(2):433-5. PubMed ID: 14857199
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of parenterally administered casein and its hydrolysis products on the exocrine secretion of the pancreas].
    Sysoev IuA; Ekimovskiĭ AP
    Vopr Pitan; 1974; (4):15-8. PubMed ID: 4217043
    [No Abstract]   [Full Text] [Related]  

  • 34. [Observations on a case of pancreatic achylia and diabetes mellitus following pancreatic necrosis. Value of greatment with massive doses of Festal].
    MARIGO S; MELANI F
    Gazz Int Med Chir; 1962 Nov; 66():2417-28. PubMed ID: 13933064
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid fractions in tissue of pathological livers and action of lipotropic factors on the intermediate metabolism of lipids in relation to their therapeutic activity].
    POLLI E; RATTI G
    Minerva Med; 1950 Jun; 41(30):1033-5. PubMed ID: 14775533
    [No Abstract]   [Full Text] [Related]  

  • 36. [Steatosis of the liver due to phosphorus. I. Lipotropic action of pantothenic acid and of its combination with meso-inositol].
    CATOLLA CAVALCANTI A; LEVIS F
    Arch Sci Med (Torino); 1950 Dec; 90(6):529-41. PubMed ID: 14811714
    [No Abstract]   [Full Text] [Related]  

  • 37. [First results of therapy with a stable lipotropic pancreatic preparation in certain hepatic diseases].
    CUTILLO F; IANNACCONE A
    Minerva Med; 1950 Jun; 41(30):1066-7. PubMed ID: 14775549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipotropic substances and fatty liver].
    CORTEVILLE M
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):832-3. PubMed ID: 13008951
    [No Abstract]   [Full Text] [Related]  

  • 39. What causes fatty liver after pancreatectomy--an unresolved and forgotten controversy. The 1936-1954 years of controversy.
    Bennett LL
    Perspect Biol Med; 1983; 26(4):595-612. PubMed ID: 6622202
    [No Abstract]   [Full Text] [Related]  

  • 40. [SOME POSSIBILITIES OF DIAGNOSIS IN DISORDERS OF PANCREATIC EXOSECRETION].
    KOSKA M
    Bratisl Lek Listy; 1964; 1():688-97. PubMed ID: 14170339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.